• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Characteristics and Prevalence of Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者心房高速率发作的临床特征及患病率
Cureus. 2024 Dec 9;16(12):e75380. doi: 10.7759/cureus.75380. eCollection 2024 Dec.
2
Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices.单核细胞与高密度脂蛋白比值在预测心脏植入式电子设备检测到的心房高率发作中的作用。
North Clin Istanb. 2018 Apr 12;5(2):96-101. doi: 10.14744/nci.2017.35761. eCollection 2018.
3
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.无房颤病史患者植入装置后的房性快速性心律失常发作:一项系统评价和荟萃分析
Cardiovasc Drugs Ther. 2022 Oct;36(5):951-958. doi: 10.1007/s10557-021-07209-8. Epub 2021 Jun 5.
4
Prevalence and Predictors of Clinically Relevant Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices.心脏植入式电子设备患者临床相关心房高速率事件的患病率及预测因素
Korean Circ J. 2021 Mar;51(3):235-247. doi: 10.4070/kcj.2020.0393.
5
Prevalence of atrial high-rate episodes and the risk factors in Indian patients with cardiac implantable electronic devices: Real-world data.印度心脏植入式电子设备患者房性高频率发作的患病率及危险因素:真实世界数据
J Arrhythm. 2019 Sep 16;35(6):830-835. doi: 10.1002/joa3.12239. eCollection 2019 Dec.
6
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.心房高频事件与植入式心脏电子设备患者主要不良心血管事件风险的关系。
Clin Res Cardiol. 2020 Jan;109(1):96-102. doi: 10.1007/s00392-019-01493-z. Epub 2019 May 29.
7
Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial.钠-葡萄糖共转运蛋白 2 抑制剂对心血管植入式电子设备患者心房高频事件的影响:一项随机对照试验。
Sci Rep. 2024 Nov 12;14(1):27649. doi: 10.1038/s41598-024-74631-x.
8
Management of atrial high-rate episodes detected by cardiac implanted electronic devices.心脏植入式电子设备检测到的心房高频事件的管理。
Nat Rev Cardiol. 2017 Dec;14(12):701-714. doi: 10.1038/nrcardio.2017.94. Epub 2017 Jul 6.
9
Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices.炎症与心脏植入式电子设备患者心房高频事件(AHREs)的风险
Clin Res Cardiol. 2018 Sep;107(9):772-777. doi: 10.1007/s00392-018-1244-0. Epub 2018 Apr 17.
10
Management of device-detected atrial high-rate episodes.设备检测到的心房高率发作的管理。
Card Electrophysiol Clin. 2015 Sep;7(3):515-25. doi: 10.1016/j.ccep.2015.05.010. Epub 2015 Jun 23.

引用本文的文献

1
Clinical- and Device-Related Factors Associated With Atrial High Rate Episodes in Patients With Dual-Chamber Pacemakers.双腔起搏器患者心房高频率发作相关的临床及设备相关因素
Cureus. 2025 Jun 19;17(6):e86376. doi: 10.7759/cureus.86376. eCollection 2025 Jun.

本文引用的文献

1
Remote monitoring of cardiac implantable electronic devices and disease management.心脏植入式电子设备的远程监测和疾病管理。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad233.
2
Prevalence of atrial high-rate episodes and the risk factors in Indian patients with cardiac implantable electronic devices: Real-world data.印度心脏植入式电子设备患者房性高频率发作的患病率及危险因素:真实世界数据
J Arrhythm. 2019 Sep 16;35(6):830-835. doi: 10.1002/joa3.12239. eCollection 2019 Dec.
3
Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.心房颤动与糖尿病:美国心脏病学会评论专题之周更
J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020.
4
Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.心房高频事件:患病率、卒中风险、对管理的影响以及证据中的临床空白。
Europace. 2019 Oct 1;21(10):1459-1467. doi: 10.1093/europace/euz172.
5
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.房颤患者抗栓治疗与 1 年随访结局的相关性:EORP-AF 一般长期注册研究。
Europace. 2019 Jul 1;21(7):1013-1022. doi: 10.1093/europace/euz032.
6
The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.糖尿病与心房颤动之间的关联:临床及机制见解
Front Physiol. 2019 Feb 26;10:135. doi: 10.3389/fphys.2019.00135. eCollection 2019.
7
Improved short and long term survival associated with percutaneous coronary intervention in the elderly patients with acute coronary syndrome.经皮冠状动脉介入治疗与老年急性冠状动脉综合征患者的短期和长期生存改善相关。
BMC Geriatr. 2018 Jun 7;18(1):137. doi: 10.1186/s12877-018-0818-z.
8
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).设备检测到的亚临床房性快速心律失常:定义、影响及管理——一份欧洲心律协会(EHRA)共识文件,得到心律学会(HRS)、亚太心律学会(APHRS)和拉丁美洲心脏刺激与电生理学会(SOLEACE)认可
Europace. 2017 Sep 1;19(9):1556-1578. doi: 10.1093/europace/eux163.
9
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
10
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.女性心房颤动:流行病学、病理生理学、临床表现和预后。
Nat Rev Cardiol. 2016 Jun;13(6):321-32. doi: 10.1038/nrcardio.2016.45. Epub 2016 Apr 7.

心脏植入式电子设备患者心房高速率发作的临床特征及患病率

Clinical Characteristics and Prevalence of Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices.

作者信息

Jaroonpipatkul Surachat, Sathapanasiri Thipsukhon, Maliang Chananan, Pokawattana Apichai, Navaravong Leenhapong

机构信息

Division of Cardiology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, THA.

Bangkok Health Research Center, Bangkok Hospital Headquarter, Bangkok Hospital, Bangkok, THA.

出版信息

Cureus. 2024 Dec 9;16(12):e75380. doi: 10.7759/cureus.75380. eCollection 2024 Dec.

DOI:10.7759/cureus.75380
PMID:39781137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11708871/
Abstract

Background Atrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs) are indicative of future clinical atrial fibrillation (AF) and stroke risk. This study aimed to investigate the prevalence of AHREs among Thai patients with CIED implantation and identify associated risk factors. Methods A retrospective observational study enrolled 278 CIED patients with AHREs lasting five minutes to 24 hours, with an average atrial rate ≥ 175 bpm, excluding known clinical AF at device implantation. Data were collected from electronic and paper medical records, and statistical analyses included Student's t-test, Mann-Whitney U test, and multivariable logistic regression. Results Of the 278 patients, 52 with pre-existing AF diagnoses were excluded. The median age was 64.86 years, with a balanced gender distribution. Hypertension was observed in 121 (53.54%) patients and diabetes in 62 (27.43%) patients. Following the designated follow-up period, 58 (20.79%) patients experienced AHREs, and eight (3.53%) developed clinical AF. Multivariable analysis confirmed diabetes as a significant risk factor for AHREs. Conclusion This study underscores the importance of monitoring AHREs for early detection of AF and stroke risk in Thai patients with CIEDs. Diabetes emerged as a significant risk factor, highlighting the need for personalized management strategies in clinical practice.

摘要

背景

心脏植入式电子设备(CIED)检测到的心房高速率发作(AHRE)提示未来临床房颤(AF)和中风风险。本研究旨在调查泰国CIED植入患者中AHRE的患病率并确定相关危险因素。方法:一项回顾性观察性研究纳入了278例AHRE持续5分钟至24小时、平均心房率≥175次/分钟的CIED患者,排除设备植入时已知的临床房颤。数据从电子和纸质病历中收集,统计分析包括学生t检验、曼-惠特尼U检验和多变量逻辑回归。结果:278例患者中,52例已有房颤诊断被排除。中位年龄为64.86岁,性别分布均衡。121例(53.54%)患者有高血压,62例(27.43%)患者有糖尿病。在指定的随访期后,58例(20.79%)患者发生AHRE,8例(3.53%)发展为临床房颤。多变量分析证实糖尿病是AHRE的一个重要危险因素。结论:本研究强调了监测AHRE对早期发现泰国CIED患者房颤和中风风险的重要性。糖尿病成为一个重要危险因素,凸显了临床实践中个性化管理策略的必要性。